Pharmathene Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Pharmathene Inc
TickerALT
CIK #0001326190
CUSIP02155H200
SectorLife Sciences - Pharmaceutical Preparations
AddressOne Park Place, Suite 450, Annapolis, MD 21401
Source [EDGAR]
CIK Filing 2011 - 2024
[0001326190] 10-K
[0001326190] 10-Q
[0001326190] 3
[0001326190] 4
[0001326190] 5
[0001326190] 8-K
[0001326190] SC 13D
[0001326190] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Janus Henderson Group PLC Altimmune Inc [2023-02-13] 7.8
Vanguard Group Inc Altimmune Inc [2023-02-09] 5.15
BlackRock Inc Altimmune Inc [2022-07-08] 2.2
Cormorant Asset Management LP Altimmune Inc [2022-07-07] 6.13
Tang Capital Partners LP Altimmune Inc [2022-03-24] 5.1
Teachers Advisors LLC Altimmune Inc [2022-02-11] 5.76
TIAA CREF Investment Management LLC Altimmune Inc [2022-02-11] 5.76
BlackRock Inc Altimmune Inc [2022-02-04] 7.4
Avidity Partners Management LP Altimmune Inc [2022-01-03] 7.0
State Street Corp Altimmune Inc [2021-09-10] 10.05
Sphera Funds Management Ltd Altimmune Inc [2021-08-31] 8.84
Venrock Healthcare Capital Partners II LP Altimmune Inc [2021-03-01] 0.99
Baker Bros Advisors LP Altimmune Inc [2021-02-16] 5.1
D E Shaw & Co LP Altimmune Inc [2020-10-05] 5.0
D E Shaw & Co LP Altimmune Inc [2020-09-24] 5.0
Venrock Healthcare Capital Partners II LP Altimmune Inc [2020-06-25] 20.8
Venrock Healthcare Capital Partners II LP Altimmune Inc [2020-06-01] 19.3
Velocity Pharmaceutical Holdings LLC Altimmune Inc [2020-02-14] 12.3
Intracoastal Capital LLC Altimmune Inc [2018-10-17] 7.6
CVI Investments Inc Altimmune Inc [2018-10-05] 0.9
Hudson Bay Capital Management LP Altimmune Inc [2018-02-02] 0.99
Hodges Philip Altimmune Inc [2017-05-15] 8.54
Truffle Capital SAS Altimmune Inc [2017-05-15] 10.1
OFCO Club V Altimmune Inc [2017-05-15] 7.5
Novartis BioVentures Ltd Altimmune Inc [2017-05-08] 11.1
JFL Capital Management LLC Pharmathene Inc [2016-10-19] 5.05
Prescott Group Capital Management LLC Pharmathene Inc [2014-04-02] 9.8
Prescott Group Capital Management LLC Pharmathene Inc [2013-09-26] 10.0
Theraclone Sciences Inc Pharmathene Inc [2013-08-12] 7.6
Form 3/4/5 Filer 2011 - 2024
Sohn Catherine A.
Pharmathene Inc
Drutz David
Eisenstadt Richard I
Harris Matthew Scott
Garg Vipin K
Roberts M Scot
Jordt Raymond M
Pisano Wayne
Gill John
Jorkasky Diane
Schafer Klaus
Sayare Mitchel
Hodges Philip
Brown William Michael
VHCP Co-Investment Holdings II, LLC
VHCP Management III, LLC
VHCP Co-Investment Holdings III, LLC
Venrock Healthcare Capital Partners II, L.P.
Venrock Healthcare Capital Partners III, L.P.
Koh Bong Y
VHCP Management II, LLC
Shah Nimish P
Velocity Pharmaceutical Holdings LLC
Watson James F
Collier David J
Velocity Pharma Management, LLC
Tasker Sybil
Novartis AG
Novartis Bioventures Ltd
Enright William
Truffle Capital S.A.S.
Schaffer Derace L
Redmont VAXN Capital Holdings, LLC
Czerepak Elizabeth
Redmont Venture Partners, Inc.
Paradigm Venture Partners, L.P.
Macneill Philip
Prescott Group Capital Management LLC
Frohlich Phil
Runge Jeffrey W.
Richman Eric I
St Peter Steven
Jones Jeffrey Michael
Chang Linda L
McCleary Joel
Markison Brian A
Morges Wayne
Cook Francesca M
Karp Jordan P
Form 13F Holdings
Firm Period DFND Voting Shares
State Street Corp [2023-03-31] DFND 4,951,654.0 4,959,254.0
Laurion Capital Management LP [2023-03-31] SOLE 3,501,330.0 3,501,330.0
Nuveen Asset Management LLC [2023-03-31] DFND 3,268,061.0 3,268,061.0
Caption Management LLC [2023-03-31] SOLE 3,106,900.0 3,106,900.0
Tang Capital Management LLC [2023-03-31] OTR 0.0 2,750,000.0
Ikarian Capital LLC [2023-03-31] SOLE 2,653,100.0 2,653,100.0
Citadel Advisors LLC [2023-03-31] DFND 2,585,185.0 2,585,185.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 2,483,552.0
Marshall Wace LLP [2023-03-31] OTR 0.0 1,597,130.0
Ardsley Advisory Partners LP [2023-03-31] SOLE 1,447,250.0 1,447,250.0
Millennium Management LLC [2023-03-31] SOLE 1,068,745.0 1,423,745.0
BlackRock Inc. [2023-03-31] SOLE 1,357,375.0 1,394,055.0
Avidity Partners Management LP [2023-03-31] SOLE 1,315,200.0 1,315,200.0
Susquehanna International Group LLP [2023-03-31] DFND 796,722.0 1,065,422.0
Two Sigma Investments LP [2023-03-31] SOLE 1,044,187.0 1,044,187.0
Bank of America Corp /DE/ [2023-03-31] DFND 0.0 996,146.0
Two Sigma Advisers LP [2023-03-31] SOLE 862,800.0 951,300.0
Goldman Sachs Group Inc [2023-03-31] DFND 855,059.0 855,059.0
Morgan Stanley [2023-03-31] DFND 733,724.0 785,521.0
Qube Research & Technologies Ltd [2023-03-31] SOLE 0.0 682,680.0
Boothbay Fund Management LLC [2023-03-31] OTR 0.0 653,760.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 527,506.0 544,727.0
TRI Locum Partners LP [2023-03-31] SOLE 528,814.0 528,814.0
Rafferty Asset Management LLC [2023-03-31] SOLE 516,563.0 516,563.0
Balyasny Asset Management LP [2023-03-31] SOLE 490,688.0 490,688.0
Geode Capital Management LLC [2023-03-31] DFND 482,361.0 482,361.0
Sectoral Asset Management Inc [2023-03-31] SOLE 209,100.0 479,100.0
Occudo Quantitative Strategies LP [2023-03-31] SOLE 434,048.0 434,048.0
GSA Capital Partners LLP [2023-03-31] SOLE 415,854.0 415,854.0
SilverArc Capital Management LLC [2023-03-31] SOLE 415,700.0 415,700.0
Prev | Page 3 | Next
Terms | Privacy | Guide
tony@aum13f.com